Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
Clinical trial NCT02970162 · COMPLETED
Trial details
- NCT number
- NCT02970162
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.